title: Infection: How should classic Whipple disease be managed?
authors.forename: Florence
authors.initials: F
authors.lastname: Fenollar
authors.forename: Didier
authors.initials: D
authors.lastname: Raoult
mesh_terms: D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D000962:Antimalarials / Q000627:therapeutic use*; D002443:Ceftriaxone / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D007275:Injections, Intravenous; D000077731:Meropenem; D055502:Secondary Prevention; D013420:Sulfamethoxazole / Q000008:administration & dosage; D013845:Thienamycins / Q000008:administration & dosage; D016896:Treatment Outcome; D014295:Trimethoprim / Q000008:administration & dosage; D054851:Tropheryma / Q000187:drug effects / Q000302:isolation & purification; D008061:Whipple Disease / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000962:Antimalarials; D013845:Thienamycins; D002443:Ceftriaxone; D014295:Trimethoprim; D000077731:Meropenem; D013420:Sulfamethoxazole